Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Legislation & Advocacy

In America’s Recession, the REF Remains Strong

  |  

According to a survey conducted in October 2008 by the Washington Regional Association of Grantmakers, three-quarters of the region’s leading foundations and corporate giving programs suffered a decline in assets because of plummeting returns on investments over 2008. About one-third of the respondents said they reduced grant budgets from 2007 to 2008, and about half of the organizations said they plan to award fewer grants in 2009.

Take Our Regulators—Please!

David S. Pisetsky, MD, PhD  |  

May 2009 bring us a return to constructive, thoughtful oversight in all fields

Fresh Chances for Advocates

Sherine Gabriel, MD  |  

Will a new year and a new president bring new advances in healthcare reform?

The Language of Lawmaking

  |  

Many people shy away from participating in advocacy efforts because they are uncomfortable with the terminology used.

I Am an Advocate

Susan Leigh  |  

Earlier this year, I was privileged to be part of the ACR’s Advocates for Arthritis advocacy visit. My rheumatologist recommended that I apply for the event, and I was thrilled when I was accepted, even though my acceptance wasn’t necessarily competitive (I was the only patient representative from Delaware).

I Am an Advocate

Deanna Sanchez Yamamoto, NP  |  

I have never considered myself to be a political person, much less an “advocate,” which is why I was surprised to become an ARHP advocacy committee member.

What a Bold Vision and Dedication Can Achieve

Leslie Crofford, MD  |  

Over the past two years, you have heard us talking a lot about Within Our Reach: Finding a Cure for Rheumatoid Arthritis, the Research and Education Foundation (REF) campaign to raise and award funds for investigator-initiated research to find a cure for rheumatoid arthritis (RA).

I Am an Advocate

Charles King, MD  |  

It was the best of times, it was the worst of times; it was the age of wisdom, it was the age of foolishness.” Cliché perhaps, but certainly fitting in describing the practice of rheumatology of late. We have been blessed with a widening array of therapies with which to treat rheumatologic illnesses. The advent of the biological era promises even greater potential for meaningful reductions in disability and death from these diseases.

Key Grassroots Opportunity

  |  

Congress is in recess August 11 through September 5. During this time, members of Congress are meeting with constituents in their district offices, so this is a great opportunity for you to…